Natera, Inc.
General ticker "NTRA" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $21.9B (TTM average)
Natera, Inc. follows the US Stock Market performance with the rate: 56.9%.
Estimated limits based on current volatility of 3.1%: low 197.84$, high 210.63$
Factors to consider:
- Total employees count: 4434 (+34.6%) as of 2024
- US accounted for 97.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Dependence on key products, Operational and conduct risks, Third-party risks, Senior management dependency, Economic downturns and volatility
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [172.60$, 308.46$]
- 2026-12-31 to 2027-12-31 estimated range: [141.68$, 263.83$]
Financial Metrics affecting the NTRA estimates:
- Negative: with PPE of -151.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0.18 <= 0.31
- Positive: Investing cash flow per share per price, % of -0.42 > -0.65
- Positive: Shareholder equity ratio, % of 68.28 > 64.25
- Positive: Inventory ratio change, % of 0.40 <= 0.80
- Positive: 0.07 < Operating cash flow per share per price, % of 0.68
- Positive: Interest expense per share per price, % of 0.01 <= 0.73
Short-term NTRA quotes
Long-term NTRA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,082.57MM | $1,696.91MM | $2,306.11MM |
| Operating Expenses | $1,528.82MM | $1,919.20MM | $2,616.02MM |
| Operating Income | $-446.25MM | $-222.29MM | $-309.91MM |
| Non-Operating Income | $11.71MM | $32.56MM | $41.82MM |
| Interest Expense | $12.64MM | $10.69MM | $4.07MM |
| R&D Expense | $320.68MM | $404.14MM | $624.11MM |
| Income(Loss) | $-434.53MM | $-189.73MM | $-268.09MM |
| Taxes | $0.27MM | $0.69MM | $-59.93MM |
| Profit(Loss)* | $-434.80MM | $-190.43MM | $-208.16MM |
| Stockholders Equity | $765.33MM | $1,195.42MM | $1,712.41MM |
| Inventory | $40.76MM | $44.74MM | $68.44MM |
| Assets | $1,441.70MM | $1,660.73MM | $2,508.04MM |
| Operating Cash Flow | $-246.96MM | $135.66MM | $215.30MM |
| Capital expenditure | $39.20MM | $66.42MM | $106.19MM |
| Investing Cash Flow | $168.50MM | $137.62MM | $-132.21MM |
| Financing Cash Flow | $254.46MM | $30.20MM | $47.46MM |
| Earnings Per Share** | $-3.78 | $-1.53 | $-1.52 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.